Lawsuit settled...new drug for seizures on the market...BD
Taro Pharmaceutical Industries Ltd. ("Taro," Pink Sheets: TAROF) reported that it settled a pending lawsuit with Novartis and will be launching Oxcarbazepine Tablets 150 mg, 300 mg, and 600 mg ("Oxcarbazepine Tablets") in the United States.
Oxcarbazepine Tablets, marketed by Novartis as Trileptal® Tablets, is a prescription pharmaceutical product used in treating seizures
0 comments :
Post a Comment